12.07.2023
WA43811 Gypsophila
A Phase Ib, Single-Arm, Open-Label Study Evaluating The Pharmacokinetics, Pharmacodynamics, And Safety Of Tocilizumab In Pediatric Patients Hospitalized With Covid-19
Show more12.07.2023
MK- 8591A-028
A Phase 2 Clinical Study to Evaluate the Pharmacokinetics, Safety, and Efficacy of Doravirine/Islatravir in Pediatric Participants with HIV-1 Infection who are Virologically Suppressed or Treatment-Naïve, are Less Than 18 Years of Age, and Weight Greater Than or Equal to 35 kg
Show more12.07.2023
TMC278IFD3004
An open-label, roll-over study with rilpivirine in combination with a background regimen containing other antiretrovirals (ARVs) in human immunodeficiency virus type 1 (HIV-1) infected subjects who participated in rilpivirine pediatric studies
Show more12.07.2023
TMC278HTX2002
A Phase 2, Open-label, Single-arm, Multicenter Study to Evaluate the Pharmacokinetics, Safety, Tolerability, and Efficacy of Switching to RPV Plus Other ARVs in HIV-1-infected Children (Aged 2 to to <12 years) who are Virologically Suppressed
Show more